<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04145843</url>
  </required_header>
  <id_info>
    <org_study_id>1504680</org_study_id>
    <nct_id>NCT04145843</nct_id>
  </id_info>
  <brief_title>Treatment Outcomes in Bile Duct Stones</brief_title>
  <official_title>Registry to Evaluate the Outcomes Following Algorithmic Approach in the Endoscopic Treatment of Bile Duct Stones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AdventHealth</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AdventHealth</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry is to evaluate the procedural and clinical outcomes in patients undergoing
      endoscopic treatment of bile duct stones when utilizing an algorithmic management approach.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gallstone diseases are common, affecting 20 million patients in the United States with
      associated costs of over US $6 billion. Common bile duct (CBD) stones in turn occur in 15-20%
      patients with gallstone disease and require treatment due to risk of infection and
      pancreatitis. Endoscopic treatment via endoscopic retrograde cholangiopancreatography (ERCP)
      is the treatment modality of choice in CBD stones. The most simple treatment techniques
      include biliary sphincterotomy and stone extraction via the use of standard devices such as a
      stone retrieval balloons or stone retrieval baskets. However, patients with difficult bile
      duct stones require advanced maneuvers namely mechanical lithotripsy, large balloon
      sphincteroplasty (LBS) of the major duodenal papilla and single operator
      cholangioscopy-guided lithotripsy (SOC-LL).

      Currently, there are no standardized treatment approaches in the management of CBD stones,
      especially in the management of difficult CBD stones. Therefore, ERCP in patients with
      difficult CBD stones can be inefficient and prolonged with use of multiple devices and
      techniques. In an effort to standardize the management of bile duct stones, we have devised
      an algorithm for the treatment of bile duct stones using current standard of care methods,
      taking into account the size of bile duct stones, size of bile duct and availability of
      endoscopic expertise. The objective of this registry is to evaluate the procedural and
      clinical outcomes in patients undergoing endoscopic treatment of bile duct stones when
      utilizing an algorithmic management approach.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 6, 2019</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of ductal clearance at index endoscopic intervention.</measure>
    <time_frame>6 months</time_frame>
    <description>Percent of patients that achieve ductal clearance at the index intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total number of needed interventions</measure>
    <time_frame>6 months</time_frame>
    <description>Total number of endoscopic interventions required for ductal clearance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure duration</measure>
    <time_frame>Index procedure</time_frame>
    <description>Length of procedure in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>Index procedure</time_frame>
    <description>Success of the procedures as documented by a yes or no.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>6 months</time_frame>
    <description>Total number of adverse events that occurred</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Crossover to other therapeutic intervention</measure>
    <time_frame>6 months</time_frame>
    <description>Need for interventional radiology or surgical intervention for bile duct stone removal as documented by yes or no.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural costs</measure>
    <time_frame>6 months</time_frame>
    <description>Total costs measured in US dollars for the procedure</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Gallstone</condition>
  <condition>Bile Duct Obstruction</condition>
  <condition>Bile Duct Diseases</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endoscopic retrograde cholangiopancreatography</intervention_name>
    <description>ERCP is a procedure that enables the physician to examine the pancreatic and bile ducts and remove gallstones.</description>
    <other_name>ERCP</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The participants will be selected from the patient population at the Center for
        interventional Endoscopy who have presented for treatment of bile duct stones.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. All patients with confirmed or suspected bile duct stones undergoing endoscopic
             therapy for treatment of bile duct stones

          2. Patients 18 years or over

        Exclusion Criteria:

          1. Patients not undergoing endoscopic therapy for bile duct stones

          2. Patients &lt; 18 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shyam Varadarajulu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Florida Hospital Orlando</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shyam Varadarajulu, MD</last_name>
    <phone>407.303.2570</phone>
    <email>Shyam.Varadarajulu.MD@adventhealth.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robin Barron, MSN</last_name>
    <phone>407.303.5503</phone>
    <email>Robin.Barron@flhosp.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Center for Interventional Endoscopy</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shyam Varadarajulu, MD</last_name>
      <phone>407-303-2750</phone>
      <email>Shyam.Varadarajulu.MD@flhosp.org</email>
    </contact>
    <contact_backup>
      <last_name>Robin E Barron-Nelson, RN, MSN</last_name>
      <phone>407.303.5503</phone>
      <email>Robin.Barron@flhosp.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>ASGE Standards of Practice Committee, Buxbaum JL, Abbas Fehmi SM, Sultan S, Fishman DS, Qumseya BJ, Cortessis VK, Schilperoort H, Kysh L, Matsuoka L, Yachimski P, Agrawal D, Gurudu SR, Jamil LH, Jue TL, Khashab MA, Law JK, Lee JK, Naveed M, Sawhney MS, Thosani N, Yang J, Wani SB. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest Endosc. 2019 Jun;89(6):1075-1105.e15. doi: 10.1016/j.gie.2018.10.001. Epub 2019 Apr 9.</citation>
    <PMID>30979521</PMID>
  </reference>
  <reference>
    <citation>Ozawa N, Yasuda I, Doi S, Iwashita T, Shimizu M, Mukai T, Nakashima M, Ban T, Kojima I, Matsuda K, Matsuda M, Ishida Y, Okabe Y, Ando N, Iwata K. Prospective randomized study of endoscopic biliary stone extraction using either a basket or a balloon catheter: the BasketBall study. J Gastroenterol. 2017 May;52(5):623-630. doi: 10.1007/s00535-016-1257-2. Epub 2016 Sep 8.</citation>
    <PMID>27631594</PMID>
  </reference>
  <reference>
    <citation>Franzini T, Moura RN, Bonif√°cio P, Luz GO, de Souza TF, Dos Santos MEL, Rodela GL, Ide E, Herman P, Montagnini AL, D'Albuquerque LAC, Sakai P, de Moura EGH. Complex biliary stones management: cholangioscopy versus papillary large balloon dilation - a randomized controlled trial. Endosc Int Open. 2018 Feb;6(2):E131-E138. doi: 10.1055/s-0043-122493. Epub 2018 Feb 1.</citation>
    <PMID>29399609</PMID>
  </reference>
  <reference>
    <citation>Brewer Gutierrez OI, Bekkali NLH, Raijman I, Sturgess R, Sejpal DV, Aridi HD, Sherman S, Shah RJ, Kwon RS, Buxbaum JL, Zulli C, Wassef W, Adler DG, Kushnir V, Wang AY, Krishnan K, Kaul V, Tzimas D, DiMaio CJ, Ho S, Petersen B, Moon JH, Elmunzer BJ, Webster GJM, Chen YI, Dwyer LK, Inamdar S, Patrick VB, Attwell A, Hosmer A, Ko C, Maurano A, Sarkar A, Taylor LJ, Gregory MH, Strand DS, Raza A, Kothari S, Harris JP, Kumta NA, Manvar A, Topazian MD, Lee YN, Spiceland CM, Trindade AJ, Bukhari MA, Sanaei O, Ngamruengphong S, Khashab MA. Efficacy and Safety of Digital Single-Operator Cholangioscopy for Difficult Biliary Stones. Clin Gastroenterol Hepatol. 2018 Jun;16(6):918-926.e1. doi: 10.1016/j.cgh.2017.10.017. Epub 2017 Oct 24.</citation>
    <PMID>29074446</PMID>
  </reference>
  <reference>
    <citation>Aburajab M, Dua K. Endoscopic Management of Difficult Bile Duct Stones. Curr Gastroenterol Rep. 2018 Mar 23;20(2):8. doi: 10.1007/s11894-018-0613-1. Review.</citation>
    <PMID>29572696</PMID>
  </reference>
  <reference>
    <citation>Cot√© GA, Singh S, Bucksot LG, Lazzell-Pannell L, Schmidt SE, Fogel E, McHenry L, Watkins J, Lehman G, Sherman S. Association between volume of endoscopic retrograde cholangiopancreatography at an academic medical center and use of pancreatobiliary therapy. Clin Gastroenterol Hepatol. 2012 Aug;10(8):920-4. doi: 10.1016/j.cgh.2012.02.019. Epub 2012 Mar 2.</citation>
    <PMID>22387254</PMID>
  </reference>
  <reference>
    <citation>Rosenkranz L, Patel SN. Endoscopic retrograde cholangiopancreatography for stone burden in the bile and pancreatic ducts. Gastrointest Endosc Clin N Am. 2012 Jul;22(3):435-50. doi: 10.1016/j.giec.2012.05.007. Epub 2012 Jun 12. Review.</citation>
    <PMID>22748241</PMID>
  </reference>
  <reference>
    <citation>Karsenti D, Coron E, Vanbiervliet G, Privat J, Kull E, Bichard P, Perrot B, Quentin V, Duriez A, Cholet F, Subtil C, Duchmann JC, Lefort C, Hudziak H, Koch S, Granval P, Lecleire S, Charachon A, Barange K, Cesbron EM, De Widerspach A, Le Baleur Y, Barthet M, Poincloux L. Complete endoscopic sphincterotomy with vs. without large-balloon dilation for the removal of large bile duct stones: randomized multicenter study. Endoscopy. 2017 Oct;49(10):968-976. doi: 10.1055/s-0043-114411. Epub 2017 Jul 28.</citation>
    <PMID>28753698</PMID>
  </reference>
  <reference>
    <citation>Buxbaum J, Sahakian A, Ko C, Jayaram P, Lane C, Yu CY, Kankotia R, Laine L. Randomized trial of cholangioscopy-guided laser lithotripsy versus conventional therapy for large bile duct stones (with videos). Gastrointest Endosc. 2018 Apr;87(4):1050-1060. doi: 10.1016/j.gie.2017.08.021. Epub 2017 Sep 1.</citation>
    <PMID>28866457</PMID>
  </reference>
  <reference>
    <citation>Varadarajulu S, Kilgore ML, Wilcox CM, Eloubeidi MA. Relationship among hospital ERCP volume, length of stay, and technical outcomes. Gastrointest Endosc. 2006 Sep;64(3):338-47.</citation>
    <PMID>16923479</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 29, 2019</study_first_submitted>
  <study_first_submitted_qc>October 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2019</study_first_posted>
  <last_update_submitted>December 20, 2019</last_update_submitted>
  <last_update_submitted_qc>December 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gallstones</mesh_term>
    <mesh_term>Cholestasis</mesh_term>
    <mesh_term>Bile Duct Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

